Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 5 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.

Combined tests may improve severe AKI detection, prediction in children

Elaine Soliven
26 Nov 2019

Combining Renal Angina Index (RAI) and urinary Neutrophil Gelatinase Associated Lipocalin (uNGAL) tests may help clinicians to detect and predict the development of severe acute kidney injury (AKI) in children admitted to the PICU*, according to a study presented at ASN Kidney Week 2019.

“Integration of the RAI and uNGAL assessments can be used early in the PICU course to identify patients truly at risk for AKI and its associated morbidity,” said study lead author Kelli Krallman, a research nurse at Cincinnati Children's Hospital Medical Center in Cincinnati, Ohio, US.

Researchers conducted a study involving 627 children who underwent an automated RAI assessment within 12 hours after PICU admission. Of these, 63 children were found to be RAI-positive (defined as an RAI score of ≥8) and were referred for an additional uNGAL assessment (cut-off value of at least 150 ng/mL). [ASN Kidney Week 2019, abstract SA-OR017]

On day 2–4 in the PICU, patients who were RAI-positive children had a significantly higher rate of severe AKI compared with those who were RAI-negative (38.0 percent vs 1.8 percent; p<0.001).

When an additional uNGAL test was performed, a significantly higher rate of severe AKI was also observed among patients positive for both RAI and uNGAL (55.5 percent vs 17.6 percent; p<0.0001) compared with patients tested negative for both RAI and uNGAL.

Of note, the need for renal replacement therapy was found to be higher among the RAI-positive group compared with the RAI-negative group (13.0 percent vs 0.4 percent; p<0.001).

RAI-positive patients also experienced a significantly longer stay in the PICU (4.6 vs 3.1 days; p<0.02) and hospital (17.8 vs 7.5 days; p<0.001) than the RAI-negative patients.

However, there was no difference in the occurrence of fluid overload between the RAI-positive and RAI-negative patients (p=0.14 vs p=0.11).

“The RAI alone continues to be a good rule-out test for severe AKI in the PICU, and [the] addition of uNGAL is promising for improved severe AKI prediction,” said the researchers, recommending that “additional research needs to be conducted on a larger sample size to better assess the clinical relevance of the RAI-[u]NGAL model in predicting severe AKI and other relevant outcomes”.

 

*PICU: Paediatric intensive care unit

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 5 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.